why choose us

First received: February 22, 2025

Clinical Trial: Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Prostate Cancer Surgery
Prostate Cancer Metastatic Disease

Study Type: INTERVENTIONAL


Official Title: Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection (Zopocianine), a Prostate-Specific Membrane Antigen (PSMA)-Targeted Fluorescent Agent, for the Intraope

Brief Summary: This study is being done to compare how well Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent imaging may improve the detection of malignant (growing in an uncontrolled way) tissue in adult subjects undergoing prostatectomy and lymph node dissection for biopsy confirmed prostate cancer.

Read more